These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 33914015)

  • 1. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
    Doan C; Li S; Goodwin JS
    JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
    Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
    JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
    Mafi JN; Craff M; Vangala S; Pu T; Skinner D; Tabatabai-Yazdi C; Nelson A; Reid R; Agniel D; Tseng CH; Sarkisian C; Damberg CL; Kahn KL
    JAMA; 2022 Jan; 327(3):237-247. PubMed ID: 35040886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer Screening.
    Resnick MJ; Graves AJ; Thapa S; Gambrel R; Tyson MD; Lee D; Buntin MB; Penson DF
    JAMA Intern Med; 2018 May; 178(5):648-654. PubMed ID: 29554179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and Colorectal Cancer Screening Utilization after Hurricane María and the COVID-19 Pandemic in Puerto Rico.
    Colón-López V; Contreras-Mora HM; Pérez CM; Berríos-Ortiz H; Sánchez-Díaz CT; Disdier OM; Ríos-Morales N; Suárez-Pérez EL
    Int J Environ Res Public Health; 2023 Oct; 20(19):. PubMed ID: 37835140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
    Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
    Hawley JE; Sun T; Chism DD; Duma N; Fu JC; Gatson NTN; Mishra S; Nguyen RH; Reid SA; Serrano OK; Singh SRK; Venepalli NK; Bakouny Z; Bashir B; Bilen MA; Caimi PF; Choueiri TK; Dawsey SJ; Fecher LA; Flora DB; Friese CR; Glover MJ; Gonzalez CJ; Goyal S; Halfdanarson TR; Hershman DL; Khan H; Labaki C; Lewis MA; McKay RR; Messing I; Pennell NA; Puc M; Ravindranathan D; Rhodes TD; Rivera AV; Roller J; Schwartz GK; Shah SA; Shaya JA; Streckfuss M; Thompson MA; Wulff-Burchfield EM; Xie Z; Yu PP; Warner JL; Shah DP; French B; Hwang C;
    JAMA Netw Open; 2022 Jan; 5(1):e2142046. PubMed ID: 34982158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
    Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
    Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations to increase rates of breast cancer screening across populations.
    Patt D; Gordan L; Patel K; Okon T; Ferreyros N; Markward N; Sullivan M; Burnett B; Getachew B; Harris C
    Am J Manag Care; 2022 Apr; 28(3 Spec. No.):SP136-SP138. PubMed ID: 35285592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
    Wang Q; Berger NA; Xu R
    JAMA Oncol; 2021 Feb; 7(2):220-227. PubMed ID: 33300956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
    Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
    JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.
    Kurani SS; McCoy RG; Lampman MA; Doubeni CA; Finney Rutten LJ; Inselman JW; Giblon RE; Bunkers KS; Stroebel RJ; Rushlow D; Chawla SS; Shah ND
    JAMA Netw Open; 2020 Mar; 3(3):e200618. PubMed ID: 32150271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.